Ventas (VTR)CEO sold ~$13.2M

~$13.2M

Approx. value · 185K sh @ $71.32

1.15M

Holds after · shares reported

Traded

Oct 20, 2025

Filed

Oct 22, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 2, 2025InsiderCEO sold ~$700K of VTR shares in the open market
2. Sep 15, 2025InsiderCEO sold ~$28K of VTR shares in the open market
3. Sep 30, 2025InsiderCEO sold ~$143K of VTR shares in the open market
4. Oct 1, 2025Insider · 2 peopleInsiders: 2 sales (~$904K)
5. Oct 20, 2025 · this disclosureInsiderCEO sold ~$13.2M of VTR shares in the open market

What came next

1. Oct 20, 2025InsiderCEO sold ~$2.44M of VTR shares in the open market
2. Oct 29, 2025Company filing · Form 8-K · ResultsReported its results
3. Oct 30, 2025Insider · 1 personInsiders: 4 sales (~$23.6M)
4. Nov 3, 2025Insider · 1 personInsiders: 2 sales (~$1.5M)
5. Nov 4, 2025Insider · 2 peopleInsiders: 2 sales (~$1.2M)
6. Nov 5, 2025Insider · 2 peopleInsiders: 2 sales (~$1.5M)
7. Nov 6, 2025Insider · 2 peopleInsiders: 2 sales (~$32K)
8. Nov 7, 2025InsiderCEO sold ~$3K of VTR shares in the open market
9. Nov 12, 2025InsiderCFO sold ~$2.58M of VTR shares in the open market
10. Nov 12, 2025CongressDisclosed purchase of VTR — reported range $1,001 - $15,000
11. Nov 14, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 17, 2025, Ventas, Inc. (the “Company”) announced that Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research, Ventas, Inc. and President and CEO, Lillibridge Healthcare Services, Inc., is expected to retire effective as of May 1, 2026 (the “Effective Date”).”
12. Nov 17, 2025InsiderCEO sold ~$3.26M of VTR shares in the open market
13. Nov 18, 2025InsiderCEO sold ~$222K of VTR shares in the open market
14. Nov 19, 2025InsiderCEO sold ~$179K of VTR shares in the open market
15. Dec 1, 2025InsiderCEO sold ~$831K of VTR shares in the open market
16. Jan 2, 2026Insider · 2 peopleInsiders: 2 sales (~$3.1M)
17. Jan 7, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
18. Jan 9, 2026CongressDisclosed partial sale of VTR — reported range $1,001 - $15,000
19. Jan 21, 20265% stakeJPMORGAN CHASE & CO. reported a passive stake (13G) of 5.9%
20. Feb 2, 2026InsiderCEO sold ~$802K of VTR shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Ventas

For Ventas, OQRO holds 1 Congress trade report and 16 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VTR page.

Other recent filings by Debra A Cafaro, Chairman and CEO

• SEC Form 4 at Ventas (VTR)Feb 10, 2026
• SEC Form 4 at Ventas (VTR)Feb 3, 2026
• SEC Form 4 at Ventas (VTR)Jan 6, 2026
• SEC Form 4 at Ventas (VTR)Dec 3, 2025
• SEC Form 4 at Ventas (VTR)Nov 19, 2025

The full history of Debra A Cafaro, Chairman and CEO is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Ventas

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its VTR page.